Franklin Biolabs and RareMoon Consulting announce a Strategic Partnership to integrate Preclinical Development with Regulatory Expertise

De-risking development of genetic medicines through integrated scientific and regulatory leadership with a focus on rare diseases and advanced therapies KING OF PRUSSIA, Pa., and WASHINGTON, May 7, 2026 /PRNewswire/ -- Franklin Biolabs, a fully integrated preclinical contract research...